Diagnosing a child with borderline signs of Asperger disorder can be a gateway to needed interventions and services and also a label that stigmatizes or influences the child’s development.
A physician argues that pharmaceutical industry support for residency programs creates a conflict of interest and compromises the educational integrity of the programs.